Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Osteosarcoma is the most common type of bone cancer in children and young adults. It usually occurs in the long bones, such as the arms or legs, though it can also occur in the pelvis, spine, jaw or other locations in the body.
Treatments for Osteosarcoma in Children
Treatments for osteocarcoma may involve a combination of therapies including surgery, radiation and/or chemotherapy. In most cases, children receive chemotherapy before surgery (neoadjuvant), a surgical procedure to remove the tumor and additional chemotherapy after surgery (adjuvant). Treatment options will vary greatly, depending on your child's situation. Your child's doctor and other members of your care team will discuss the options with you in-depth. Prompt medical attention and aggressive therapy are important for the best prognosis.
How Dana-Farber/Boston Children’s approaches osteosarcoma
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center provides comprehensive medical and surgical care for children and adolescents with bone tumors, such as osteosarcoma. Our multidisciplinary approach through our Bone and Soft Tissue Program ensures in-depth discussion of each case and personalized treatment plans for every patient. We integrate expertise from pediatric oncologists, oncologic orthopedists, pediatric specialists, psychologists, social workers, and oncologic surgeons.
Find more in-depth information on osteosarcoma on the Dana-Farber/Boston Children's website, including answers to:
For many children with rare or hard-to-treat conditions, clinical trials provide new options.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”